f your doctor says that you have metastatic breast cancer, it means the cancer has spread beyond your breasts to other parts of your body. There's no cure, but treatments can ease your symptoms, slow down the cancer's growth, and help you live longer.
You may also hear people call your condition "stage IV" or "advanced breast cancer." When you get a diagnosis, your doctor will explain that cancer cells from your breasts moved through your bloodstream or lymphatic system -- a network of channels, nodes, and glands that help you fight disease. As a result, cancer cells show up in distant areas.
The kind of treatment you get has a lot to do with where your cancer has spread. Your doctor will also suggest treatments based on things like:
Some treatments work better on different kinds of breast cancer cells. To find out more about your cells, your doctor will take samples of your blood and tissue. They're sent to a lab, where technicians look at them under a microscope. This can reveal what's making your cells grow, so you can take a medicine that targets that feature.
Your doctor may tell you that you have one of these types of metastatic breast cancer cells:
Hormone-receptor-positive. These cells have proteins called hormone "receptors." The job of these receptors is to catch -- or "bind" to -- certain hormones as they move through your body. If you have hormone-receptor-positive breast cancer, the receptors bind to estrogen and progesterone hormones. These hormones stimulate the growth of breast cancer cells. In most cases, breast cancer is hormone-receptor positive.
Hormone-receptor-negative. The cells don't have hormone receptors.
HER2-positive. A gene called human epidermal growth factor receptor 2 (HER2) makes HER2 protein. These proteins act as receptors. Some breast cancer cells make too many HER2 proteins. When this happens, the cells grow faster than usual.
HER2-negative in women with a PIK3CA mutation. If you have this type, your cancer cells don't have large amounts of HER2 protein. You'll also have signs of a mutation (change) on a gene called the PIK3CA. This may play a role in how the cells turn cancerous.
HER2-negative in women with a BRCA mutation. Along with a normal amount of HER2 protein, you have a mutation on the BRCA 1 or 2 gene. This can lead to abnormal cell growth.
Triple-negative. This kind of breast cancer takes its name from things that your cancer cells are lacking. The cells don’t have many estrogen or progesterone receptors, or a lot of HER2 protein. About 20% of the time, triple-negative tumors make a protein called PD-L1, which can play a useful role in certain treatments.
Based on your cancer and medical history, your doctor will suggest the treatments that are most likely to work with the fewest side effects. Some treatments are "systemic," which means they work on your entire body. Others are local, or focus on one area. You may need one treatment or a combination of them.
Hormone therapy is often the first treatment your doctor will suggest if you have hormone-receptor-positive cancer. This treatment works by stopping hormones from attaching to the receptors. It may block the receptor or lower the amount of estrogen that your body makes. This prevents breast cancer cell growth.
This drug blocks estrogen receptors in breast cells. You usually take it every day as a pill.
It's a once-a-day pill that works like tamoxifen to prevent estrogen from attaching to cancer cells. The FDA has approved it only for women who have already gone through menopause.
This medicine also blocks and damages estrogen receptors. Doctors often suggest it if you've tried other hormone therapies, such as tamoxifen, but they aren't working anymore. Sometimes they recommend it for advanced breast cancer if you haven't been treated with other hormone therapies. You usually take fulvestrant as a shot every 2 weeks for 1 month, and then once a month. The FDA has approved it for women who are done with menopause, but doctors sometimes prescribe it for premenopausal women, too.
These drugs stop an enzyme from making estrogen. Doctors prescribe them if you're finished with menopause. You take it every day as a pill.
In rare cases, you may get more serious side effects, such as:
It's rare, but tamoxifen can raise your risk of uterine cancer.
Your doctor may suggest radiation therapy to ease symptoms and control cancer in certain areas of your body. This treatment uses high-energy X-rays or other particles to kill cancer cells. For example, if your breast cancer has spread to your liver, radiation may help shrink the tumor. This can help lessen the pain.
A machine sends out high-energy rays that pass through your skin into the tumor.
Different beams target a tumor to deliver a high dose of radiation.
These drugs are made of a radioactive substance. You take the drug as an injection into a vein or artery, or you swallow it, and it gives off radiation and kills cancer cells.
Chemotherapy uses chemicals to kill fast-growing cancer cells. It's the main option if you have hormone-receptor-negative cancer. Your doctor may also suggest it if you tried hormone therapy and it didn't work. Chemotherapy is also a choice if your cancer is growing quickly or causing symptoms.
Several different chemotherapy drugs can treat metastatic breast cancer. Your doctor will choose one or more based on the type of cancer cells you have. You may need to take them separately, one after another, or as a combination.
You take some chemotherapy medicines as pills. You get others through an IV.
Chemotherapy drugs can't tell the difference between cancer and normal cells. They damage healthy cells, which causes side effects. During treatment, you may have:
Talk to your doctor if you have any of these problems. They can suggest medicines that can give you relief.
Months or years after chemotherapy, other side effects may show up, such as:
These drugs zero in on certain cancer cells. They block specific molecules involved in the growth and spread of cancer. And some targeted drugs may not have as many side effects as chemotherapy.
Your doctor will suggest a targeted therapy based on your cancer cells. You could get the medicine as an injection, through an IV, or as a pill.
It curbs the activity of CDK4 and CDK6 enzymes, which helps stop cancer cells from dividing and growing.
This medication is a combination of a generic form of Herceptin and a chemotherapy drug.
This drug is a type called a "P13K inhibitor." You might use it if you have HER2-negative, hormone-receptor-positive cancer cells with a P1K3CA mutation.
It blocks the growth of new blood vessels in your cancer cells.
Your doctor may suggest this drug if you have hormone-receptor-positive, HER2-negative cancer. It blocks a protein called mTOR and helps limit growth of cancer cells.
This medication attaches the HER2 antibody to the chemotherapy drug deruxtecan, delivering the drug directly to HER2 proteins in cancer cells.
It blocks certain proteins in HER2-positive cells.
Your doctor might suggest this drug if they've tried at least two other HER2-targeted drugs. It can be used along with chemotherapy.
This drug treats early-stage breast cancer. It's typically given after you've been treated with trastuzumab for one year. It can also be used with the chemo drug capecitabine, usually after at least two other HER2-targeted drugs have been tried.
This drug curbs the action of an enzyme called PARP. The job of PARP is to repair DNA damage in cells. That's OK if it's fixing damaged healthy cells, but it's not so useful when it's repairing cancer cells. Your doctor may suggest Lynparza if you have HER2-negative cells with a BRCA mutation.
It prevents hormone-receptor-positive, HER2-negative cells from dividing and growing. They target enzymes called CDK4 and CDK6.
This medicine blocks HER2 receptors.
It blocks CDK4 and CDK6 enzymes to prevent breast cancer cells from dividing and growing.
This medication attaches to the Trop-2 protein on breast cancer cells, taking a chemo drug directly to them. Too much Trop-2 protein helps breast cancer cells grow and spread quickly. This drug can be used to treat triple negative breast cancer after other chemotherapies have been tried.
It blocks the PARP enzymes. You might use it if you have HER2-negative cells with a BRCA mutation.
This medicine attaches to HER2 receptors to keep breast cancer cells from getting growth signals.
This drug can be used after your doctor has tried at least one other HER2 targeted drug. It's often given with trastuzumab and the chemo drug capecitabine.
In rare cases, some targeted therapies may lead to a hole in the gastrointestinal tract, called a gastrointestinal perforation.
There are many targeted therapy drugs in the research pipeline. Some of them target CDK4 and CDK6 enzymes and HER2 receptors.
Your doctor may suggest you take any of the targeted therapy drugs now approved by the FDA for metastatic breast cancer along with chemotherapy.
Immunotherapy helps your body's own immune system fight cancer cells. Your doctor will recommend it if you have triple-negative tumors that make the PD-L1 protein.
Checkpoint inhibitors work by targeting proteins in immune cells that doctors call "checkpoints." The checkpoint inhibitors "lift the brakes" on these immune cells so that they can attack your cancer cells.
This medicine is a checkpoint inhibitor used for high-risk, early-stage, triple-negative breast cancer (TNBC). It's done along with chemotherapy. It can also be given to treat metastatic TNBC when the tumor makes PD-L1 protein.
Surgery is sometimes an option if your metastatic cancer is the first time you've been diagnosed with breast cancer. Your doctor may also suggest it if a tumor's causing a lot of symptoms or if there's a risk of a serious complication. For example, if your breast cancer has spread and presses on your spinal cord, it may lead to leg weakness.
In this procedure, a doctor puts a cold probe into your tumor to freeze the tissue.
Cryoablation, like any procedure, can have side effects. You might get:
If your breast cancer has spread to your bones, your doctor may suggest drugs that prevent breaks and ease bone pain.
This drug interferes with osteoclasts, the cells that break down bone tissue. You take it as shot that you get once a month.
This medicine also blocks osteoclasts. You take it through an IV every 1 to 3 months.
In rare cases, bone-strengthening drugs may cause kidney problems or bone damage in the jaw from osteonecrosis.
These are treatments that ease symptoms and pain, but they don't fight the disease. You may have palliative care along with your other treatments.
The goal of palliative care is to make you feel as comfortable as possible. It may help lessen pain, symptoms, and the side effects of treatment, such as nausea and dizziness. It may improve your appetite, boost your energy, and help you sleep better. It can include medicines, such as anti-nausea drugs and antidepressants.
These natural products and mind-body practices may help ease treatment side effects. They may also curb stress and improve your quality of life. Before you try one, check with your doctor that it's safe and won't react badly with any of your treatments.
There are many kinds of complementary treatments, including:
A practitioner puts thin needles into points in your skin. This is meant to activate the release of natural painkillers.
This hands-on therapy may help with stress and pain.
In this practice, you focus on a relaxed mental and physical state. It may help ease stress, fatigue, and more.
This mind-body practice may lessen stress, anxiety, and fatigue.
These may include herbs, vitamins, minerals, and probiotics.
Researchers are trying all the time to find new treatments for metastatic breast cancer. They test drugs, devices, or procedures in studies called "clinical trials" to see if they work well and are safe. Ask your doctor if joining one is a good idea for you.
If you take part in a clinical trial, you get a chance to try treatments that aren't available to the public yet. The medications you get in the trial might improve your condition or ease symptoms. By joining a clinical trial, you'll also help doctors add to their knowledge of breast cancer care and improve the treatment of people in the future.
Some clinical trials may test brand-new drugs. Others check to see if medicine that's already used for another purpose may help treat metastatic breast cancer. Researchers also want to know if it’s helpful to combine medications in new ways.
No matter what kind of treatment the clinical trial is testing, researchers want to find out things like:
Keep in mind that you're in charge of your treatment journey. Some cancer treatment side effects can be tough. It's OK to talk to your doctor about taking a break. You can work out a plan, and your medical team can help you stay comfortable until you decide whether or not to start cancer treatment again. You should also set up a schedule to check in on a regular basis.